Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DionyMed Brands Inc (Sub Voting) DYMEF

DionyMed Brands Inc is a multi-state cannabis brand and distribution platform based in Canada. The company provides support to cultivators and manufacturers of medical and adult-use cannabis products. It sells branded products in every category from flower to vape cartridges, concentrates, and edibles. Geographically, it derives a majority revenue from the United States of America. The company also provides services such as Logistics Services and Software, Warehousing and Co-Packing, Manufacturi


GREY:DYMEF - Post by User

Comment by Tradertimestwoon Apr 16, 2019 4:10pm
113 Views
Post# 29635445

RE:RE:RE:C$10 Million Bought Deal Private Placement

RE:RE:RE:C$10 Million Bought Deal Private PlacementNot too worried. The real investors will hold thier shares till its much more than 4.25 anyways. I will stick with them.
BenjaminGraham2 wrote: Was actually shocked to see that they did the raise at $2.75 when they did their last raise at $4.25 in November, basically indicating to the market that they overpriced their last raise by 35% and have now diluted those holders. They most recent raise has a warrant that can be executed at $3.80 which will add a further overhang in the November round getting back to even. All in all management has screwed over the $4.25 investor round. Also keep in mind, $18m of debentures are convertable into common at $2.07. Lots of overhang on this name.


<< Previous
Bullboard Posts
Next >>